AIM Biotech
PrivateLast Round
Grant
Aug 20, 2021
Momentum
Top 10%
of companies Caplight tracks
Company Overview
AIM Biotech operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Grant round in August 2021.
AIM Biotech is a biotechnology company that develops and provides organ-on-a-chip systems, also known as 3D cell culture platforms, for use in medical research, drug discovery, and clinical investigation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AIM Biotech Comparables
Compare AIM Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beonchip | 89% | |
| AlveoliX AG | 88% | |
| Akita | 86% |
For institutional investors. Book with your work email.
AIM Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 20, 2021 | ||||
| Series A | Nov 19, 2020 | ||||
| Seed | Sep 4, 2016 |
For institutional investors. Book with your work email.
AIM Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SEEDS Capital | Series A |
| Black Kite Capital | Series A |
| Wavemaker Three-Sixty Health | Series A |
| Wavemaker Ventures | Series A |
| Venturecraft | Series A, Seed |
| SMART Innovation Centre | Grant |
| Elev8.vc | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors grew 94% MoM.
- Jul 25, 2026
Monthly visitors increased 31% MoM, reaching 4.3K.
For institutional investors. Book with your work email.
AIM Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AIM Biotech's valuation, stock price, and market status.
Is AIM Biotech a public or private company?
AIM Biotech is a private company.
What is the current stock price of AIM Biotech?
AIM Biotech is a private company, so its shares have no public market price. Caplight tracks AIM Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AIM Biotech worth (valuation)?
Valuation information for AIM Biotech is not publicly available.
Can I buy AIM Biotech stock?
AIM Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AIM Biotech's last funding round?
AIM Biotech's most recent funding round was Grant on August 20, 2021.
Who are the main investors in AIM Biotech?
Key investors in AIM Biotech include Wavemaker Ventures.
Will AIM Biotech IPO soon?
No public IPO plans have been announced for AIM Biotech.
How can I track AIM Biotech secondary market activity?
Caplight tracks bids, offers, and trades in AIM Biotech's shares on secondary markets.